Who Paid My Doc
Mark Stewart
Neuromusculoskeletal Medicine, Sports Medicine Bay City, MI Medical Doctor
NPI 1205805579 CMS profile 327054
4 Columbus Ave, Ste 360, Bay City, MI 48708
General payments
$1,079
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Mark Stewart of Bay City, MI is reported in the CMS Open Payments database as having received $1,079 across 38 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 76th percentile of Neuromusculoskeletal Medicine, Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $54 | 3 | |
| 2024 | General | $30 | 1 | |
| 2023 | General | $184 | 9 | |
| 2022 | General | $163 | 10 | |
| 2021 | General | $94 | 4 | |
| 2020 | General | $55 | 3 | |
| 2019 | General | $499 | 8 |
Beside peers
- Mark Stewart
- Neuromusculoskeletal Medicine, Sports Medicine median
- Middle half of Neuromusculoskeletal Medicine, Sports Medicine
- National median
In program year 2025, general payments to Mark Stewart were reported at $54. Among 69 Neuromusculoskeletal Medicine, Sports Medicine profiles paid that year, the median was $125 and the middle half received between $37 and $473.
Show as a table
| Year | Mark Stewart | Neuromusculoskeletal Medicine, Sports Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $499 | $152 | $43–$474 | $163 |
| 2020 | $55 | $113 | $31–$725 | $114 |
| 2021 | $94 | $167 | $50–$469 | $132 |
| 2022 | $163 | $132 | $46–$572 | $149 |
| 2023 | $184 | $109 | $39–$366 | $160 |
| 2024 | $30 | $115 | $37–$321 | $164 |
| 2025 | $54 | $125 | $37–$473 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 5 drugsPart D claims
201
Drug cost
$1,275
Branded share of claims
55.7%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 101 | $670 | |
| Cephalexin | Generic | 55 | $358 | |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 11 | $125 | |
| Ciprofloxacin Hcl | Generic | 19 | $98 | |
| Tramadol Hcl | Generic | 15 | $25 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 116 billing codesPaid by Medicare
$109,128
Medicare patients
142
Services billed
7,874
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 75% | |
| Ischemic heart disease | 46% | |
| Depression | 38% | |
| Chronic kidney disease | 37% | |
| Diabetes | 35% | |
| COPD | 30% | |
| Atrial fibrillation | 26% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 | Office | 53 | 868 | $655 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
38 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neuromusculoskeletal Medicine, Sports Medicine in Michigan
Kenneth Mueller
Neuromusculoskeletal Medicine, Sports Medicine · Hillsdale, MI
Bruce Trusock
Neuromusculoskeletal Medicine, Sports Medicine · Houghton, MI
Herbert Mendelson
Neuromusculoskeletal Medicine, Sports Medicine · Livonia, MI
Val Syring
Neuromusculoskeletal Medicine, Sports Medicine · Grand Rapids, MI
Mark Rottenberg
Neuromusculoskeletal Medicine, Sports Medicine · Farmington Hills, MI
Fredric Levin
Neuromusculoskeletal Medicine, Sports Medicine · Muskegon, MI
Related records
Neuromusculoskeletal Medicine, Sports Medicine in Michigan
Practitioners in the same specialty and state, ranked by reported value.
All Neuromusculoskeletal Medicine, Sports Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Michigan
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.